Development of a novel Ara h 2 hypoallergen with no IgE binding or anaphylactogenic activity

BACKGROUND: To date, no safe allergen-specific immunotherapy for patients with peanut allergy is available. Previous trials were associated with severe side effects. OBJECTIVE: We sought to determine the relative importance of conformational and linear IgE-binding epitopes of the major peanut allerg...

詳細記述

保存先:
書誌詳細
出版年:J Allergy Clin Immunol
主要な著者: Tscheppe, Angelika, Palmberger, Dieter, van Rijt, Leonie, Kalic, Tanja, Mayr, Vanessa, Palladino, Chiara, Kitzmüller, Claudia, Hemmer, Wolfgang, Hafner, Christine, Bublin, Merima, van Ree, Ronald, Grabherr, Reingard, Radauer, Christian, Breiteneder, Heimo
フォーマット: Artigo
言語:Inglês
出版事項: 2020
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7100897/
https://ncbi.nlm.nih.gov/pubmed/31525384
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2019.08.036
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料